ASRM Corporate Member Council In-Training Travel Awards

Fifteen awards to trainee abstract presenters from the United States and five awards to trainee abstract presenters from countries outside the United States are made possible through the generous support of the ASRM Corporate Member Council. Recipients of this award are undergraduate, graduate, medical or allied health professions students, postdoctoral trainees, or clinical residents or fellows. Candidates are the first and presenting author of an abstract that has been selected for oral or poster presentation in the ASRM 2017 Scientific Congress. Selection is based on the scientific merit of the abstract and the qualifications of the author. The awardees receive:

  • $1,000 (US presenters)
  • $2,000 (Non-US presenters)

Congratulations to the 2018 Winners

  • O-3, JOINT IMPACT OF MATERNAL AGE AND BMI ON CUMULATIVE LIVE BIRTH FOLLOWING IN VITRO FERTILIZATION R. H. Goldman, L. V. Farland, A. M. Thomas, C. A. Zera, E. S. Ginsburg; Obstetrics & Gynecology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA
  • O-5, TESTOSTERONE TREATMENT ALTERS PLACENTAL ANGIOGENESIS, INFLAMMATION, AND OXIDATIVE STRESS THROUGHOUT GESTATION IN A SHEEP MODEL OF POLYCYSTIC OVARY SYNDROME A. S. Kelley,1 M. Puttabyatappa,2 Y. R. Smith,1 V. Padmanabhan3; 1Obstetrics and Gynecology, Michigan Medicine, Ann Arbor, MI, 2Pediatrics, University of Michigan, Ann Arbor, MI, 3Pediatrics, Reproductive Endocrinology, Ann Arbor, MI
  • O-15, ANDROGENIC ALOPECIA ASSOCIATED WITH THE HSD3B1 (1245A>C) IN OVERWEIGHT WOMEN WITH POLYCYSTIC OVARIAN SYNDROME Y. Tu, S. Chen, J. Yang, H. Ho, M. Chen; National Taiwan University Hospital, Taipei, Taiwan
  • O-17, AEROBIC PHYSICAL TRAINING REDUCES ANTHROPOMETRIC INDEXES AND HYPERANDROGENISM IN POLYCYSTIC OVARY SYNDROME C. L. Miranda-Furtado,1 V. B. Ribeiro,1 I. P. Lopes,1 R. C. Silva,1 G. S. Kogure,1 D. C. Pedroso,2 R. A. Ferriani,3 R. M. Reis4; 1Ginecology and Obstetrics, Ribeirao Preto Medical School, Ribeirao Preto, Brazil, 2Ribeirào Preto Medical School, University of Sào Paulo, Ribeirào Preto, Brazil, 3Obstetrics and Gynecology, University of Sao Paulo, Ribeirao Preto, Brazil, 4Ribeirao Preto Medical School, Ribeirao Preto, Brazil
  • O-28, USING OF ANTI-IL-6 RECEPTOR MONOCLONAL ANTIBODIES IN TREATMENT OF ENDOMETRIOSIS: PROOF OF CONCEPT A. A. El-Zayadi,1 S. A. Mohamed,1 M. Arafa,2 A. M. Badawy1; 1Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt, 2Pathology, Mansoura University, Mansoura, Egypt
  • O-53, ESTRADIOL INCREASES GAMMA-AMINOBUTYRIC ACID (GABA) LEVELS IN HUMAN UMBILICAL VASCULAR ENDOTHELIAL CELLS. A. A. Armstrong,1 D. Shan,2 A. Yoon,3 K. F. Faull,3 S. Ramadoss,2 G. Chaudhuri,4 L. Nathan5; 1OB/GYN, University of California, Los Angeles, Los Angeles, CA, 2University of California, Los Angeles, Los Angeles, CA, 3Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, 4OB/GYN Reproductive Endocrinology and Infertility, University of California Los Angeles, Los Angeles, CA, 5OB/GYN, University of California Los Angeles, Los Angeles, CA
  • O-67, A RANDOMIZED CONTROLLED TRIAL OF COMBINATION OF LETROZOLE AND CLOMIPHENE CITRATE VERSUS LETROZOLE ALONE FOR OVULATION INDUCTION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME R. Mejia,1 K. M. Summers,2 J. D. Kresowik,3 B. J. Van Voorhis4; 1Ob-Gyn, Division of Reproductive Endocrinology & Infertility, University of Iowa, Iowa City, IA, 2Research Assistant, Iowa City, IA, 3Ob-Gyn, University of Iowa Hospitals and Clinics, Iowa City, IA, 4Ob-Gyn, University of Iowa College of Medicine, Iowa City, IA
  • O-82, BONE MARROW-DERIVED ENDOMETRIAL CELLS EXPRESS ANDROGEN RECEPTOR K. Krishnamoorthy, A. Owusu-Akyaw, L. T. Goldsmith, S. S. Morelli; Obstetrics, Gynecology, & Women's Health, Rutgers - New Jersey Medical School, Newark, NJ
  • O-92, PRECONCEPTION AND PRENATAL EXPOSURE TO ENVIRONMENTAL CHEMICALS AND THE RISK OF PRETERM BIRTH J. Yland,1 L. Minguez-Alarcon,2 J. B. Ford,2 P. L. Williams,3 A. Azevedo1,2 J. A. Attaman,4 R. Hauser,2 C. Messerlian2; 1Department of Epidemiology, Harvard Chan School of Public Health, Boston, MA, 2Department of Environmental Health, Harvard Chan School of Public Health, Boston, MA, 3Departments of Biostatistics and Epidemiology, Harvard Chan School of Public Health, Boston, MA, 4Obstetrics & Gynecology, Massachusetts General Hospital Fertility Center, Boston, MA
  • O-93, FSH SIGNALING IN HUMAN GRANULOSA CELLS IS AUGMENTED BY THE PKA REGULATORY II SUBUNIT AND RHO-GEF BINDING REGIONS OF A-KINASE ANCHORING PROTEIN 13 (AKAP13) A. Sewdass, S. Ng, S. Su, P. H. Driggers, J. H. Segars; Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD
  • O-95, GONADOTROPIN STIMULATION HAS DIFFERENTIAL EFFECTS ON OOCYTE AND EMBRYO DEVELOPMENT: EVIDENCE FROM A MOUSE MODEL C. Sullivan-Pyke, S. Mani, T. Ord, C. Krapp, M. Bartolomei, M. Mainigi; University of Pennsylvania, Philadelphia, PA
  • O-96, OBSTETRIC OUTCOMES IN PREGNANCIES RESULTING FROM IN VITRO FERTILIZATION (IVF) ARE NOT DIFFERENT IN FERTILE, STERILIZED PATIENTS COMPARED TO INFERTILE WOMEN: A SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY (SART) DATABASE ANALYSIS V. R. Libby,1 M. Chung,2 E. Dilday,2 C. Ahn,3 S. Babayev,2 R. Weinerman,1 K. Doody4; 1Reproductive Endocrinology and Infertility, University Hospitals Fertility Center, Beachwood, OH, 2OB/GYN, UT Southwestern, Dallas, TX, 3Dept. of Clinical Sciences, UT Southwestern, Dallas, TX, 4Center for Assisted Reproduction, Bedford, TX
  • O-154, IMPACT OF YOGA- AND MEDITATION-BASED LIFESTYLE INTERVENTION ON DEPRESSION, QUALITY OF LIFE, AND CELLULAR AGING IN INFERTILE COUPLES M. R. Tolahunase,1 R. Sagar,2 P. Chaurasia,1 R. Dada1; 1Lab for Molecular Reproduction and Genetics, Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India, 2Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India
  • O-162, THE INTERPLAY OF AMH, ADIPOSITY AND CARDIOMETABOLIC HEALTH E. Greenwood,1 J. Sroga-Rios,2 M. Pavone,3 M. Cedars,1 R. S. Legro,4 H. G. Huddleston1; 1UCSF, San Francisco, CA, 2Obstetrics and Gynecology, University of Cincinnati College of Medicine, West Chester, OH, 3Northwestern Medicine, Chicago, IL, 4Pennsylvania State University, Hershey, PA
  • O-184, THE IMPACT OF LOW DOSE ASPIRIN ON THE MODE OF DELIVERY: SECONDARY ANALYSIS OF THE EFFECT OF ASPIRIN IN GESTATION AND REPRODUCTION (EAGER) TRIAL A. Eubanks,1 C. J. Nobles,2 S. Mumford,3 M. J. Hill,4 A.H. DeCherney,5 L. A. Sjaarda,2 N. Perkins,5 R. Silver,6 E. Schisterman5; 1Walter Reed National Military Medical Center, Bethesda, MD, 2Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, 3The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, 4NIH, Germantown, MD, 5NICHD, Bethesda, MD, 6University of Utah, Salt Lake City, UT
  • O-197, ONLY PATIENTS WITH OBVIOUS ADENOMYOSIS ON THREE-DIMENSIONAL ULTRASOUND (3D US) ARE AT INCREASED RISK OF CLINICAL LOSS FOLLOWING FROZEN EMBRYO TRANSFER S. A. Neal,1,2 L. R. Goodman,1 S. Morin,1,2 M. D. Werner,1 N. Gueye,3 A. W. Tiegs,1,2 P. Pirtea,1 R. Scott1; 1IVI/RMA, Basking Ridge, NJ, 2Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 3RMA Pennsylvania, Allentown, PA
  • O-216, CONCENTRATION OF COLONY-STIMULATING GROWTH FACTOR (CSF) IN UTERINE FLUSHING AS PROGNOSTIC CRITERION OF IVF CYCLE OUTCOME IN PATIENTS WITH RECURRENT IMPLANTATION FAILURE D. Obidniak,1,2 A. Gzgzyan,2 A. Kalugina,1 D. Niauri2; 1Assisted Reproductive Technology, Ava-Peter, Saint-Petersburg, Russian Federation, 2Medical Faculty, St.Petersburg State University, Saint-Petersburg, Russian Federation
  • O-230, PATIENT-CENTERED CARE: FACTORS ASSOCIATED WITH REPORTING A POSITIVE EXPERIENCE AT U.S. FERTILITY CLINICS L. Shandley,1 L. J. McKenzie,1 H. Hipp,1 J. Anderson-Bialis,2 D. Anderson-Bialis,2 J. F. Kawwass1; 1Emory Reproductive Center, Atlanta, GA, 2FertilityIQ, San Francisco, CA
  • O-238, OOCYTE SECRETED FACTORS REGULATE INSULIN GROWTH FACTOR 2 (IGF2) EXPRESSION IN HUMAN PRIMARY CUMULUS GRANULOSA CELLS E. Hobeika,1 M. Armouti,2 M. Fierro,1 N. Winston,1 H. Scoccia,1 A. M. Zamah,1 C. Stocco2; 1Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, 2Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL
  • O-254, LOW DOSE ASPIRIN AND MENSTRUAL CYCLE CHARACTERISTICS M. B. Evans,1 C. J. Nobles,1 K. Kim,1 M. J. Hill,1 A. H. DeCherney,1 R. Silver,2 S. Mumford,1 N. Perkins,1 E. Schisterman1; 1NIH-NICHD, Bethesda, MD, 2University of Utah, Salt Lake City, UT

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew